Congenital heart disease and thyroid dysfunction in Down syndrome reported at Children`s Hospital, Lahore, Pakistan

Muhammad Yaqoob1, Jaida Manzoor2, Syed Najam Hyder3

  • 1University Institute of Public Health, University of Lahore, 1-km Defense Road, Lahore.

Insights

Congenital heart disease and thyroid dysfunction are common in children with Down syndrome. Early detection and management of these conditions are crucial for reducing illness and death in this population.

Area of Science:

  • Pediatrics
  • Genetics
  • Endocrinology

Background:

  • Down syndrome, a leading cause of intellectual disability, is associated with various co-morbid conditions.
  • Congenital heart disease (CHD) and thyroid dysfunction are frequently observed in individuals with Down syndrome.
  • Understanding the prevalence of these conditions is vital for improving patient outcomes.

Purpose of the Study:

  • To determine the frequency of congenital heart disease and thyroid dysfunction in children with Down syndrome.
  • To analyze the types of CHD and thyroid abnormalities present in this cohort.
  • To emphasize the importance of early screening and management.

Main Methods:

  • A retrospective record-based study was conducted.
  • Children diagnosed with Down syndrome based on clinical features and chromosomal analysis (extra chromosome 21) were included.
  • CHD diagnosis utilized echocardiography; thyroid dysfunction was identified through abnormal serum levels of tetraiodothyronine and thyroid-stimulating hormone.

Main Results:

  • 350 children with Down syndrome were enrolled; 60% were males.
  • Congenital heart defects were identified in 41.8% of cases, with ventricular septal defect being the most common (41%).
  • Thyroid dysfunction was present in 22% of cases, including 5.9% with hypothyroidism.

Conclusions:

  • The study highlights a high frequency of congenital heart disease and thyroid dysfunction in children with Down syndrome.
  • Early referral to tertiary healthcare facilities is recommended for timely diagnosis and management.
  • Effective management of these comorbid conditions can significantly reduce morbidity and mortality in children with Down syndrome.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...